MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
5.98
-0.69
-10.29%
After Hours: 6.02 +0.05 +0.75% 19:59 05/09 EDT
OPEN
6.61
PREV CLOSE
6.66
HIGH
6.64
LOW
5.80
VOLUME
20.02M
TURNOVER
--
52 WEEK HIGH
23.86
52 WEEK LOW
4.430
MARKET CAP
967.76M
P/E (TTM)
-4.8498
1D
5D
1M
3M
1Y
5Y
1D
Novavax Price Target Cut to $7.00/Share From $9.00 by JP Morgan
Dow Jones · 12h ago
Novavax Is Maintained at Underweight by JP Morgan
Dow Jones · 12h ago
JP Morgan Maintains Underweight on Novavax, Lowers Price Target to $7
Benzinga · 12h ago
Novavax Inc. Stock Falls 10.3%, Underperforms Competitors
Dow Jones · 12h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stoke Therapeutics (STOK), Novavax (NVAX) and McKesson (MCK)
TipRanks · 20h ago
Novavax price target lowered to $7 from $9 at JPMorgan
TipRanks · 1d ago
Novavax Reports Strong Q1 2025 Earnings
TipRanks · 1d ago
Novavax Faces Financial and Regulatory Challenges Amid Uncertain Vaccine Prospects
TipRanks · 1d ago
More
About NVAX
More
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Recently
Symbol
Price
%Change

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.